/ Aug 15, 2026
/ Aug 15, 2026

New pancreatic cancer drug doubles survival time in major trial

Published on

By

A new experimental drug has raised fresh hope for patients battling advanced pancreatic cancer after a major international clinical trial found it significantly improved survival rates compared to standard chemotherapy.

 

According to a report by TheCable, the once-daily pill, daraxonrasib, helped patients with advanced pancreatic cancer live an average of 13.2 months, compared with 6.6 months for those receiving chemotherapy.

The trial involved 500 patients across North America, Europe and Asia. Of those participants, 248 received daraxonrasib while 252 were treated with chemotherapy.

Researchers said the drug targets the KRAS gene mutation, which is present in more than 90 per cent of pancreatic cancer cases and plays a key role in tumour growth and spread. The treatment was also associated with fewer side effects than chemotherapy.

The findings were presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, held from May 29 to June 2.

Rachna Shroff, chief of the division of haematology and oncology at the University of Arizona Cancer Centre, described the results as a major breakthrough for patients with metastatic pancreatic cancer carrying a KRAS mutation.

“These results are landscape-changing for metastatic pancreatic cancer patients with a KRAS mutation,” Shroff said.

Although pancreatic cancer is relatively uncommon in Nigeria compared with many Western countries, it remains one of the deadliest cancers. Data from the Global Cancer Observatory shows the disease ranks 19th in cancer incidence in the country, with 1,283 new cases and 1,344 deaths recorded.

Health experts say pancreatic cancer is often diagnosed at an advanced stage because symptoms can be difficult to detect early. Common signs include fatigue, unexplained weight loss, poor appetite, nausea, dark urine, itchy skin and jaundice.

The American Society of Clinical Oncology said daraxonrasib will now be submitted to the US Food and Drug Administration for evaluation and possible approval as a treatment for pancreatic cancer.

You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Must Read

Nasarawa State Governor Abdullahi Sule at the signing of a $2 million supplementary lithium agreement with Chinese investors in Abuja.

Governor Sule seals $2m Lithium deal with Chinese Firm

Nasarawa State Governor Abdullahi Sule has presided over the signing of a $2 million supplementary lithium agreement between the state government and Diamond New Energy, following his recent visit to China.   The agreement was signed at the Nasarawa State Governor’s Lodge in Abuja on Friday, August 14, 2026. Sule said the deal would help keep the company’s lithium processing factory operational while protecting jobs created by the investment. > “We are going to keep your factory functional, and we also have an interest as license owners in whatever you are doing in your company. More importantly, the people you have employed will remain employed,” the governor said. According to Channels Television, the governor said the state moved quickly to secure the relevant mining licence to ensure continued access to raw materials and prevent another party from obtaining the licence. The Commissioner for Environment and Natural Resources, Margaret Elayo, expressed appreciation to the investors and said the partnership could encourage further investment in Nasarawa. The signing was witnessed by officials from the state Ministry of Justice, Ministry of Environment and Natural Resources, the Nasarawa State Investment Development Agency (NASIDA), Diamond New Energy and Ganfeng Lithium Industry Limited. Sule also urged the company to maintain peaceful relations with host communities and contribute to their development. He disclosed that payments due to the state under the agreement would be made in foreign currency directly to Nasarawa Mining Company Limited, with the terms subject to periodic review. Agreement builds on 2024 mining deal NASIDA Managing Director and Chief Executive Officer Ibrahim Abdullahi said the state government had signed an exclusive mining cooperation agreement with the company in 2024. He said the partnership had contributed to the completion of what he described as the largest lithium processing refinery in West Africa. The supplementary agreement allows the continued supply of lithium materials from the state government’s mining block to serve as feedstock for the refinery. Abdullahi said the arrangement was expected to create further employment opportunities for young people and women in Nasarawa. He added that the state would receive $2 million immediately upon signing, with additional revenues expected under the agreement. A representative of Diamond New Energy, David Siong, said the company remained committed to expanding its operations in Nasarawa, including local processing of resources, job creation and supporting economic development in host communities. The Attorney-General and Commissioner for Justice, Isaac Danladi, also presented copies of a deed of assignment transferring the mining rights and interests of Nasarawa Mining Company within 3.5 mining cadastral units in Endo, Nasarawa Local Government Area, to Ganfeng Lithium Industry Limited.
Read more

Editor's Pick

Trending News

Newsletter

Enter your email address and receive notifications of news by email.

You have been successfully Subscribed! Ops! Something went wrong, please try again.

© 2026 GongNews. All Rights Reserved.